Using Blood to Track Brain Cancer
Can a simple blood test tell us more about brain cancer? A study from researchers in Italy says yes, and it all comes down to a tiny but powerful mutation in a gene called IDH1 . Gliomas are a type of brain tumor, and diagnosing or tracking them usually means getting a tissue sample from the brain, which is an invasive and risky procedure. But what if we could just use blood? That’s the idea behind liquid biopsy , a method that looks for cancer-related DNA floating in the bloodstream. It’s already used in some cancers like lung and breast. But brain tumors are tricky because the brain is protected by the blood-brain barrier , which makes it harder for tumor DNA to reach the blood. A study set out to find whether a mutation called IDH1 p.R132H , commonly found in gliomas, could still be detected in blood, and whether that detection means anything for patient outcomes. How the Study Worked 67 glioma patients were included in the study. Researchers checked if the IDH1 mutation foun...
